4//SEC Filing
Mattila Jyrki 4
Accession 0001062993-19-002408
CIK 0000875622other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 7:23 PM ET
Size
11.5 KB
Accession
0001062993-19-002408
Insider Transaction Report
Form 4
Mattila Jyrki
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2019-05-22−15,000→ 0 totalExercise: $37.64Exp: 2025-04-22→ Common Stock (15,000 underlying) - Sale
Common Stock, $0.001 par value
2019-05-22$62.06/sh−18,750$1,163,625→ 376 total - Exercise/Conversion
Stock Option (right to buy)
2019-05-22−3,750→ 11,250 totalExercise: $41.82Exp: 2028-03-15→ Common Stock (3,750 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2019-05-22$37.64/sh+15,000$564,600→ 15,376 total - Exercise/Conversion
Common Stock, $0.001 par value
2019-05-22$41.82/sh+3,750$156,825→ 19,126 total
Footnotes (2)
- [F1]The options were granted on April 22, 2015 and vested in four equal annual installments beginning on the first anniversary of the grant date.
- [F2]The options were granted on March 15, 2018, and vest in four equal annual installments beginning on the first anniversary of the grant date.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001297318
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 7:23 PM ET
- Size
- 11.5 KB